KNSA compared with ANIP: revenue, margins and what each company keeps, and the suppliers and customers both name

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

ANIPANI Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

KNSAKiniksa Pharmaceuticals International, plc

ANIPANI Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KNSA2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.9%▲+22.23%×1.60

Q2 FY26—▲+25.03%—

ANIP

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.4%▼−5.30%×0.63

May 8 '26±8.2%▼−2.44%×0.29

= impliedKNSA realized, solidANIP realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedspan: KNSA 91d · ANIP 206dSource: market data

Q1 FY26

±11.5%

▼−4.21%

×0.37

Jan 13 '26±5.0%▼−2.45%×0.50

KNSAKiniksa Pharmaceuticals International, plc

90.92▼−1.43%· post 92.39

Mkt cap$7.2BRevenue$286MQ3 FY26Revenue$678MFY25

ANIPANI Pharmaceuticals Inc

71.88▼−0.17%· post 70.69

ClosedNov 2 '26

Mkt cap$1.6BRevenue$266MQ2 FY26Revenue$883MFY25

Compare

ClosedNov 2 '26

KNSAKiniksa Pharmaceuticals International, plc

ANIPANI Pharmaceuticals Inc

90.92▼−1.43%post 92.39

Price

71.88▼−0.17%post 70.69

$7.2B

Mkt cap

$1.6B

Q3 FY26$286M

Revenue

$266MQ2 FY26

FY25$678M

Revenue

$883MFY25

KNSA90.92▼−1.43%vsANIP71.88▼−0.17%ClosedNov 2 '26